IAC ltd supply antigen tests. Both the test aRoche SARS-CoV-2 Antigen Test and PANBIO™ COVID-19 Ag RAPID TEST are on the approved list of Antigen test approved by the EU
Roche SARS-CoV-2 Antigen Test [SD BIOSENSOR] The benefit of having a SARS-CoV-2 antigen test available
The SARS-CoV-2 virus causes respiratory tract infection. It is transmitted mainly via respiratory droplets after close contact, and primary viral replication is presumed to occur in mucosal epithelium of the upper respiratory tract (nasal cavity and pharynx).1 At these locations viral load peaks within the first week after symptom onset, and then declines.2
A SARS-CoV-2 antigen test detects the presence of the SARS-CoV-2 virus from part of the upper respiratory tract swab specimens by identifying a nucleoprotein that is carried by the virus. The test identifies current infection during the acute phase of COVID-19, while the virus is still present in large quantities in the respiratory tract.
Roche SARS-CoV-2 Nasal Antigen Test
The benefits of the SARS-CoV-2 Rapid Antigen Test Nasal in short:
- Using a nasal swab for quick and convenient specimen collection
- Getting a quick result within 15-30 minutes – no need for a follow-up appointment to discuss the result
- Providing patients with the option to self-collect their nasal sample
- Allowing decentralized testing or access to testing in areas where laboratory testing is not available
Accessible, easy-to-deploy, large-scale testing helps contain the virus spread.